American Diabetes Association Professional Practice Committee. 2. Diagnosis and classification of diabetes: Standards of Care in Diabetes—2024. Diabetes Care 2024;47(Suppl. 1):S20–S42
Shi K, et al. Reduced thoracic skeletal muscle size is associated with adverse outcomes in diabetes patients with heart failure and reduced ejection fraction: quantitative analysis of Sarcopenia by using cardiac MRI. Cardiovasc Diabetol. 2024;23(1):28.
Article CAS PubMed PubMed Central Google Scholar
Huang Y, et al. Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis. BMJ. 2016;355:i5953.
Article PubMed PubMed Central Google Scholar
Sarwar N, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375(9733):2215–22.
Article CAS PubMed Google Scholar
Liu F, et al. Associations between long-term exposure to ambient air pollution and risk of type 2 diabetes mellitus: a systematic review and meta-analysis. Environ Pollut. 2019;252Pt B:1235–45.
Chen M et al. How long-term air pollution and its metal constituents affect type 2 diabetes mellitus prevalence? Results from Wuhan Chronic Disease Cohort. Environ Res, 2022. 212(Pt A): p. 113158.
Wang Y, et al. Associations of long-term exposure to ambient air pollutants with metabolic syndrome: the Wuhan Chronic Disease Cohort Study (WCDCS). Environ Res. 2022;206:112549.
Article CAS PubMed Google Scholar
Hou J, et al. Long-term exposure to ambient air pollution attenuated the association of physical activity with metabolic syndrome in rural Chinese adults: a cross-sectional study. Environ Int. 2020;136:105459.
Article CAS PubMed Google Scholar
Zang ST, et al. Air pollution and metabolic syndrome risk: evidence from nine observational studies. Environ Res. 2021;202:111546.
Article CAS PubMed Google Scholar
Landrigan PJ, et al. The Lancet Commission on pollution and health. Lancet. 2018;391(10119):462–512.
Cohen AJ, et al. Estimates and 25-year trends of the global burden of disease attributable to ambient air pollution: an analysis of data from the Global Burden of diseases Study 2015. Lancet. 2017;389(10082):1907–18.
Article PubMed PubMed Central Google Scholar
Liang S, et al. Long-term exposure to ambient ozone and cardiovascular diseases: evidence from two national cohort studies in China. J Adv Res. 2024;62:165–73.
Article CAS PubMed Google Scholar
Liu X, et al. Oil mist particulate matter induces myocardial tissue injury by impairing fatty acid metabolism and mitochondrial bioenergetics function via inhibiting the PPAR alpha signaling pathway in rats. Environ Pollut. 2025;365:125340.
Article CAS PubMed Google Scholar
Feng S, et al. The health effects of ambient PM2.5 and potential mechanisms. Ecotoxicol Environ Saf. 2016;128:67–74.
Article CAS PubMed Google Scholar
Matthiessen C, et al. Long-term exposure to airborne particulate matter and NO(2) and prevalent and incident metabolic syndrome - results from the Heinz Nixdorf Recall Study. Environ Int. 2018;116:74–82.
Article CAS PubMed Google Scholar
Mirowsky JE, et al. Ozone exposure is associated with acute changes in inflammation, fibrinolysis, and endothelial cell function in coronary artery disease patients. Environ Health. 2017;16(1):126.
Article PubMed PubMed Central Google Scholar
Panasevich S, et al. Associations of long- and short-term air pollution exposure with markers of inflammation and coagulation in a population sample. Occup Environ Med. 2009;66(11):747–53.
Article CAS PubMed Google Scholar
Karam BS, et al. Oxidative stress and inflammation as central mediators of atrial fibrillation in obesity and diabetes. Cardiovasc Diabetol. 2017;16(1):120.
Article PubMed PubMed Central Google Scholar
Karakayali M, et al. Serum malondialdehyde levels at admission as a predictor of inhospital mortality in patients with acute coronary syndrome. Coron Artery Dis; 2024.
Karakayalı M, Artaç ÖM, Omar İ, İliş T, Arslan D, Çağın A, Altunova Z, Karabağ M, Rencüzoğulları Y. Inducible nitric oxide synthase (iNOS) is a potential marker of myocardial infarction with non-obstructive coronary artery Disease (MINOCA). Bagcilar Med Bull. 2024 Sep;9(3):188–95.
Chen Y, et al. Neutrophils to high-density lipoprotein cholesterol ratio as a new prognostic marker in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a retrospective study. BMC Cardiovasc Disord. 2022;22(1):434.
Article CAS PubMed PubMed Central Google Scholar
Rizo-Téllez SA, Sekheri M, Filep JG. C-reactive protein: a target for therapy to reduce inflammation. Front Immunol. 2023;14:1237729.
Article PubMed PubMed Central Google Scholar
Che B, et al. Triglyceride-glucose index and triglyceride to high-density lipoprotein cholesterol ratio as potential cardiovascular disease risk factors: an analysis of UK biobank data. Cardiovasc Diabetol. 2023;22(1):34.
Article CAS PubMed PubMed Central Google Scholar
Gao Y, et al. The predictive value of the hs-CRP/HDL-C ratio, an inflammation-lipid composite marker, for cardiovascular disease in middle-aged and elderly people: evidence from a large national cohort study. Lipids Health Dis. 2024;23(1):66.
Article CAS PubMed PubMed Central Google Scholar
Karakayali M, et al. The relationship between the systemic Immune-inflammation index and ischemia with non-obstructive coronary arteries in patients undergoing coronary angiography. Arq Bras Cardiol. 2024;121(2):e20230540.
Tran HM, et al. The impact of air pollution on respiratory diseases in an era of climate change: a review of the current evidence. Sci Total Environ. 2023;898:166340.
Article CAS PubMed Google Scholar
Zhao Y, et al. Cohort profile: the China Health and Retirement Longitudinal Study (CHARLS). Int J Epidemiol. 2014;43(1):61–8.
Marx N, et al. 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. Eur Heart J. 2023;44(39):4043–140.
Article CAS PubMed Google Scholar
Wei J, et al. The ChinaHighPM(10) dataset: generation, validation, and spatiotemporal variations from 2015 to 2019 across China. Environ Int. 2021;146:106290.
Article CAS PubMed Google Scholar
Wei J, et al. Full-coverage mapping and spatiotemporal variations of ground-level ozone (O3) pollution from 2013 to 2020 across China. Remote Sens Environ. 2022;270:112775.
Luo H, et al. Long-term exposure to ambient air pollution is a risk factor for trajectory of cardiometabolic multimorbidity: a prospective study in the UK Biobank. EBioMedicine. 2022;84:104282.
Article CAS PubMed PubMed Central Google Scholar
Bai L, et al. Exposure to ambient air pollution and the incidence of congestive heart failure and acute myocardial infarction: a population-based study of 5.1 million Canadian adults living in Ontario. Environ Int. 2019;132:105004.
Article CAS PubMed Google Scholar
Chen X, et al. Respiratory inflammation and short-term Ambient Air Pollution exposures in Adult Beijing residents with and without prediabetes: a panel study. Environ Health Perspect. 2020;128(6):67004.
Article CAS PubMed Google Scholar
Fuks KB, et al. Long-term exposure to ambient air pollution and traffic noise and incident hypertension in seven cohorts of the European study of cohorts for air pollution effects (ESCAPE). Eur Heart J. 2017;38(13):983–90.
Lawler PR, et al. Targeting cardiovascular inflammation: next steps in clinical translation. Eur Heart J. 2021;42(1):113–31.
留言 (0)